HIV and AIDS

This is a  series of first person experiences of love, struggle, doubt, happiness and strength. Four people candidly share their real stories. Four artists have worked with the storytellers to create original artwork inspired by their stories.

This fact sheet provides basic information about U=U. It opens with the question: Did you know that having an undetectable viral load on HIV treatment (ART) stops HIV transmission?

The PrEP Communications Accelerator is a free interactive, digital resource that supports national governments, program implementers, and health practitioners to develop marketing and communications that drive demand for PrEP in sub-Saharan Africa. 

The Evidence for Contraceptive Options and HIV Outcomes (ECHO) trial was launched in 2015 to test the comparative risk of HIV acquisition among women using one of the following three contraceptive methods: depo-medroxyprogesterone acetate intramuscular (DMPA-IM), also known as Depo-Provera, two-rod levonorgestrel sub-dermal implant (LNG-Implant), branded as Jadelle, and the copper intrauterine device (Copper-IUD). 

Nepal's health sector needs accurate, comprehensive and disaggregated data to gauge its performance, identify disparities between social groups and geographic areas, and plan future interventions. 

Pages